|
Originally published In Press as doi:10.1194/jlr.M300432-JLR200 on December 16, 2003
Journal of Lipid Research, Vol. 45, 543-550, March 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse
David Masson1,2,*,
Bart Staels1, ,
Thomas Gautier*,
Catherine Desrumaux*,
Anne Athias*,
Naig Le Guern*,
Martina Schneider*,
Zoulika Zak*,
Laure Dumont*,
Valérie Deckert*,
Alan Tall ,
Xian-Cheng Jiang** and
Laurent Lagrost*
* Institut National de la Santé et de la Recherche Médicale U498, Faculté de Médecine, BP87900, 21079 Dijon Cedex, France
Institut National de la Santé et de la Recherche Médicale U545, Département d'Athérosclérose, Institut Pasteur de Lille, BP245, 59019 Lille Cedex, France
Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY 10032
** State University of New York, Downstate Medical Center, Brooklyn, NY 11203
2 To whom correspondence should be addressed. e-mail: david.masson{at}chu-dijon.fr
Human plasma, unlike mouse plasma, contains the cholesteryl ester transfer protein (CETP) that may influence the reverse cholesterol transport. Liver X receptor (LXR), an oxysterol-activated nuclear receptor induces CETP transcription via a direct repeat 4 element in the CETP gene promoter. The aim of the study was to assess in vivo the impact of LXR activation on CETP expression and its consequences on plasma lipid metabolism and hepatic and bile lipid content. Wild-type and humanized mice expressing CETP were treated for five days with T0901317 LXR agonist. This treatment produced marked rises in both hepatic CETP mRNA and plasma CETP activity levels. Interestingly, the LXR agonist-mediated, 2-fold rise in both total and HDL cholesterol levels in treated wild-type mice was not observed in CETPTg mice, and the accumulation of cholesterol in the liver of CETPTg mice was reversed by LXR agonist treatment. Moreover, LXR activation induced a 2-fold increase in hepatic LDL-receptor expression in wild-type and CETPTg mice, and it produced a significantly greater rise in biliary cholesterol concentration in CETPTg mice as compared with wild-type mice.
In conclusion, induction of CETP constitutes a major determinant of the effect of LXR agonists on cholesterol transport and excretion.
Abbreviations: CE, cholesteryl ester; CETP, cholesteryl ester transfer protein; LXR, liver X receptor; PLTP, phospholipid transfer protein; RCT, reverse cholesterol transport; SREBP, sterol-responsive element binding protein Supplementary key words bile cholesterol low density lipoprotein receptor reverse cholesterol transport transgenic mice

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Calpe-Berdiel, N. Rotllan, C. Fievet, R. Roig, F. Blanco-Vaca, and J. C. Escola-Gil
Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
J. Lipid Res.,
September 1, 2008;
49(9):
1904 - 1911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Thomassen, B. P. Barna, A. G. Malur, T. L. Bonfield, C. F. Farver, A. Malur, H. Dalrymple, M. S. Kavuru, and M. Febbraio
ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis
J. Lipid Res.,
December 1, 2007;
48(12):
2762 - 2768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Drouineaud, P. Sagot, C. Garrido, E. Logette, V. Deckert, P. Gambert, C. Jimenez, B. Staels, L. Lagrost, and D. Masson
Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists
Mol. Hum. Reprod.,
June 1, 2007;
13(6):
373 - 379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gautier, U. J. F. Tietge, R. Boverhof, F. G. Perton, N. Le Guern, D. Masson, P. C. N. Rensen, L. M. Havekes, L. Lagrost, and F. Kuipers
Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein
J. Lipid Res.,
January 1, 2007;
48(1):
30 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven
Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2006;
26(4):
706 - 715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Masson, L. Lagrost, A. Athias, P. Gambert, C. Brimer-Cline, L. Lan, J. D. Schuetz, E. G. Schuetz, and M. Assem
Expression of the Pregnane X Receptor in Mice Antagonizes the Cholic Acid-Mediated Changes in Plasma Lipoprotein Profile
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2005;
25(10):
2164 - 2169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Coutinho, R. R. Singaraja, M. Kang, D. J. Arenillas, L. N. Bertram, N. Bissada, B. Staels, J.-C. Fruchart, C. Fievet, A. M. Joseph-George, et al.
Complete functional rescue of the ABCA1-/- mouse by human BAC transgenesis
J. Lipid Res.,
June 1, 2005;
46(6):
1113 - 1123.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|